Teladoc drops as Cantor calls telehealth a 'commodity'

Teladoc Health has come under pressure after Cantor Fitzgerald reiterated its commodity-like outlook on telehealth. Analysts Steven Halper and Kyle Mikson reaffirm their neutral rating on the stock with a price target of $210.00 per share to imply a ~21.8% upside to the last close. The duo cites a Wall Street Journal article in which Erik Sossa former head of benefits at Pepsico indicated that ‘telehealth is kind of a commodity.’